For the purpose of the study on androgens in urological fields, urinary 17-ketosteroid fractions and Testosterone Radioactivity were determined by using the modified KANBEGAWA'S method (1967), and a few experimental studies on male urines were made.
Urinary 17-Ketosteroids were fractionated into Dyhydroepiandrosterone (DHA), Androsterone (ANDRO), Etiocholanolone (ETIO), 11-β-hydroxy-androsterone (11-OXY-A), 11-β-hydroxy-etiocholanolone (11-OXY-E), 11-keto-androsterone (11-OXO-A), and 11-keto-etiocholanolone (11-OXO-E) by the use of gradient elution chromatography.
In respect of Testosterone Radioactivity, after Testosterone-4-
14C injection, the position and ratio of Testosterone-4-
14C's radioactivity in urinary 17-Ketosteroid fractions were determined.
The outline of procedure was as follows:
After intravenous injection of Testosterone-4-
14C 1-1.2μc (or Testosterone-4-
14C 1-1.2μc and DHA-
3H 2-4μc), urine was collected for 3 days. Utilizing 200ml of each of their 24 hour urine, the following technique was done. That is, urinary 17-Ketosteroid fractions were determined with β-gluculonidase hydrolysis, solvolysis, saponification, gradient elution chromatography, and spectrophotometry. All radioactive counting was done in a Packard Tri-Garb liquid scintillation spectrometer.
The results of experimental studies were as follows:
(A) Urinary 17-Ketosteroid fractions:
1) Prostatic cancer:
In urinary 17-Ketosteroid fractions, the level of Etiocholanolone was much higher than Androsterone, then, the ANDRO-ETIO ratio was low. In the so-called adrenal fractions of urinary 17-Ketosteroid, DHA was low, but 11-keto-17KS and 11-β-hydroxy-17KS were high as compared with healthy male subjects.
Following castration, levels of urinary total 17-Ketosteroid, Androsterone, Etiocholanolone and DHA were reduced, but, 11-keto-17KS and 11-β-hydroxy-17KS were increased
2) Male Hypogonadism:
Levels of urinary total 17-Ketosteroid. were low as compared with the healthy male, but 11-keto-Androsterone was high. The pattern of their fractions did not differ significantly from those of a healthy male.
(B) Testosterone Radioactivity:
1) Healthy Male:
The peak of Testosterone Radioactivity in urinary 17-Keto-steroid fractions was observed in the frac tion of Androsterone.
2) Prostatic cancer:
The peak of Testosterone Radioactivity in urinary 17-Keto-steroid fractions was transfered to Etiocholanolone from Androsterone.
After castration, it was nearly the same.
3) Male Hypogonadism:
Testosterone Radioactivity of male hypogonadism was nearly the same as that of a healthy male.
View full abstract